IonQ (NYSE: IONQ) insider plans 25,000-share Rule 144 stock sale

Rhea-AI Filing Summary

IonQ, Inc. insider Rima Alameddine has filed a Form 144 notice to sell 25,000 shares of IonQ common stock through Morgan Stanley Smith Barney LLC on the NYSE around 11/28/2025, with an aggregate market value of 1,172,500.00. IonQ had 354,279,591 shares of common stock outstanding.

The 25,000 shares to be sold were acquired on 12/10/2023 as restricted stock units from the issuer. Over the prior three months, the seller completed additional common stock sales, including 100,000 shares on 11/20/2025 for gross proceeds of 4,689,060.00 and 19,976 shares on 09/11/2025 for gross proceeds of 886,966.36, identified as 10b5-1 sales for Rima Alameddine.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	1172500.00	354279591	11/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/10/2023	Restricted Stock Units	Issuer			25000	12/10/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for RIMA ALAMEDDINE 4505 Campus Drive College Park MD 20740	Common	11/20/2025	100000	4689060.00
RIMA ALAMEDDINE 4505 Campus Drive College Park MD 20740	Common	09/11/2025	19976	886966.36

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IonQ (IONQ)'s latest Form 144 filing disclose?

The filing states that an insider, Rima Alameddine, has notified of an intent to sell 25,000 shares of IonQ common stock on the NYSE, with an aggregate market value of 1,172,500.00.

How many IonQ (IONQ) shares are planned to be sold and at what value?

The notice covers 25,000 shares of IonQ common stock with an indicated aggregate market value of 1,172,500.00, to be sold through Morgan Stanley Smith Barney LLC.

How were the IonQ (IONQ) shares in this Form 144 acquired?

The 25,000 shares covered by the notice were acquired on 12/10/2023 as restricted stock units from IonQ, with the same date listed as the date of payment and the nature of payment shown as N/A.

What prior IonQ (IONQ) share sales has the insider reported in the last three months?

Over the previous three months, the insider reported selling 100,000 common shares on 11/20/2025 for gross proceeds of 4,689,060.00 and 19,976 shares on 09/11/2025 for gross proceeds of 886,966.36, described as 10b5-1 sales for Rima Alameddine.

How many IonQ (IONQ) shares are outstanding according to this notice?

The Form 144 disclosure lists 354,279,591 IonQ common shares as outstanding, providing a baseline for the company's total share count.

Which broker and exchange are involved in the planned IonQ (IONQ) share sale?

The planned sale of 25,000 IonQ common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE.